Search Results 591-600 of 11394 for anti-TNF drugs

1. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Cohort A will enroll participants who have progressed on prior standard of care treatment with an anti-PD-1/PD-L1 antibody and a platinum-based chemotherapy ...

2. NSAIDS Archives - Mayo Clinic News Network

   DEAR MAYO CLINIC: Is it true that taking prescription-strength nonsteroidal anti-inflammatory drugs, or NSAIDs, can increase my risk of heart disease? How much ...

3. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... * have not progressed on treatment with an anti-PD(L)1 mAb * have not ...

4. An Open-label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Treatment with any systemic anti-lymphoma therapy within 5 half-lives or within 28 days prior to first administration of study drug, whichever is shorter.

5. Mayo experts provide insights into how genes affect medication response

   William Freeman, M.D.. Pharmacogenomics testing can also play a key role in identifying those patients who take anti-seizure medications who may be at risk for ...

6. COPD - Diagnosis and treatment - Mayo Clinic

   This ongoing lung disease limits airflow into and out of the lungs. This results in trouble breathing, cough with mucus and wheezing.

7. A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Participants With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments - Mayo Clinic

   ... drugs for the treatment of a blood cancer called multiple myeloma. ... Prior treatment with anti-PD-1 or anti-PD-L1 agents. Prior exposure to ...

8. A Study To Test The Addition Of The Immunotherapy Drug Pembrolizumab To The Usual Chemotherapy Treatment (Paclitaxel And Carboplatin) In Stage III-IV Or Recurrent Endometrial Cancer - Mayo Clinic

   This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer. Participation ...

9. An Extension Study Monitoring The Safety Of Patients With Crohn's Disease Previously Enrolled In The Etrolizumab Phase III Study GA29144 - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Use of TNF antagonists;; Use of antagonists of ... Use of anti-adhesion molecules (e.g., anti-MAdCAM-1).

10. Pemigatinib To Treat Metastatic Or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... Anti-VEGF (vascular endothelial growth factor) ...